These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pulmonary infiltration and bone marrow depression complicating treatment with amiodarone. Wright AJ; Brackenridge RG Br Med J (Clin Res Ed); 1982 May; 284(6325):1303. PubMed ID: 6803952 [No Abstract] [Full Text] [Related]
4. Lung disease caused by amiodarone, a new antiarrythmic agent. Gefter WB; Epstein DM; Pietra GG; Miller WT Radiology; 1983 May; 147(2):339-44. PubMed ID: 6836114 [TBL] [Abstract][Full Text] [Related]
5. Diffuse alveolar damage syndrome associated with amiodarone therapy. Jirik FR; Henning H; Huckell VF; Ostrow DV Can Med Assoc J; 1983 May; 128(10):1192-5. PubMed ID: 6839242 [TBL] [Abstract][Full Text] [Related]
6. Gallium scintigraphy in the detection of amiodarone lung toxicity. Moinuddin M; Rockett J AJR Am J Roentgenol; 1986 Sep; 147(3):607-9. PubMed ID: 3488662 [TBL] [Abstract][Full Text] [Related]
7. Gallium-67 lung uptake associated with amiodarone pulmonary toxicity. Dake MD; Hattner R; Warnock ML; Golden JA Am Heart J; 1985 May; 109(5 Pt 1):1114-6. PubMed ID: 3993525 [No Abstract] [Full Text] [Related]
8. [Formation of multiple round foci in the lung during amiodarone therapy]. Criée CP; Wilhelms E; Kneba M; Kreuzer H Dtsch Med Wochenschr; 1984 Mar; 109(13):499-500. PubMed ID: 6705699 [TBL] [Abstract][Full Text] [Related]